Evidence map›Paper›PMID 22250084›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2012

Membrane-tethered MUC1 mucin is phosphorylated by epidermal growth factor receptor in airway epithelial cells and associates with TLR5 to inhibit recruitment of MyD88.

Kosuke Kato, Erik P Lillehoj, Yong Sung Park, Tsuyoshi Umehara, Nicholas E Hoffman, Muniswamy Madesh, K Chul Kim

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. MUC1 in the upper-lower airway inflammatory continuum: an endotype-centered perspective.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  3. Review
  4. iScience · 2024
    Article
  5. Article
  6. Article
  7. Innate immune responses in pneumonia.Pneumonia (Nathan Qld.) · 2023
    Review
  8. Article
  9. Review
  10. The role of mucin 1 in respiratory diseases.European respiratory review : an official journal of the European Respiratory Society · 2021
    Review
  11. Review
  12. The interaction ofMicrobiology (Reading, England) · 2020
    Article
  13. MUC1 contributes to goblet cell metaplasia and MUC5AC expression in response to cigarette smoke in vivo.American journal of physiology. Lung cellular and molecular physiology · 2020
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kosuke KatoDepartment of Physiology, Center for Inflammation, Translational and Clinical Lung Research, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Erik P Lillehoj
Yong Sung Park
Tsuyoshi Umehara
Nicholas E Hoffman
Muniswamy Madesh
K Chul Kim
Temple University · USUniversity of Maryland, Baltimore · US

Funding

SIGNALING MECHANISM OF MUC1 MUCINR01HL047125 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI KIM, KWANG CHUL · 1991 to 2015
$4.5M
Coordination of Pathophysiologic Endothelial Cell Signaling by ROSR01HL086699 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI MUNISWAMY, MADESH · 2008 to 2018
$4.3M
Anti-inflammatory role of MUC1 mucinR01HL081825 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI KIM, KWANG CHUL · 2006 to 2010
$2.2M
Counter-Regulation of TLR-Driven Mucosal InflammationR21AI083463 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LILLEHOJ, ERIK P · 2009 to 2010
$375k
NHLBI NIH HHS HL-47125NHLBI NIH HHS HL-81825NHLBI NIH HHS HL-86699NHLBI NIH HHS R01 HL047125NHLBI NIH HHS R01 HL081825NIAID NIH HHS AI-83463NIAID NIH HHS R21 AI083463
6 · The paper itself

Abstract

MUC1 is a membrane-tethered mucin glycoprotein expressed on the apical surface of mucosal epithelial cells. Previous in vivo and in vitro studies established that MUC1 counterregulates airway inflammation by suppressing TLR signaling. In this article, we elucidate the mechanism by which MUC1 inhibits TLR5 signaling. Overexpression of MUC1 in HEK293 cells dramatically reduced Pseudomonas aeruginosa-stimulated IL-8 expression and decreased the activation of NF-κB and MAPK compared with cells not expressing MUC1. However, overexpression of MUC1 in HEK293 cells did not affect NF-κB or MAPK activation in response to TNF-α. Overexpression of MyD88 abrogated the ability of MUC1 to inhibit NF-κB activation, and MUC1 overexpression inhibited flagellin-induced association of TLR5/MyD88 compared with controls. The MUC1 cytoplasmic tail associated with TLR5 in all cells tested, including HEK293T cells, human lung adenocarcinoma cell line A549 cells, and human and mouse primary airway epithelial cells. Activation of epidermal growth factor receptor tyrosine kinase with TGF-α induced phosphorylation of the MUC1 cytoplasmic tail at the Y46EKV sequence and increased association of MUC1/TLR5. Finally, in vivo experiments demonstrated increased immunofluorescence colocalization of Muc1/TLR5 and Muc1/phosphotyrosine staining patterns in mouse airway epithelium and increased Muc1 tyrosine phosphorylation in mouse lung homogenates following P. aeruginosa infection. In conclusion, epidermal growth factor receptor tyrosine phosphorylates MUC1, leading to an increase in its association with TLR5, thereby competitively and reversibly inhibiting recruitment of MyD88 to TLR5 and downstream signaling events. This unique ability of MUC1 to control TLR5 signaling suggests its potential role in the pathogenesis of chronic inflammatory lung diseases.

Indexed as

AnimalsCell LineEpithelial CellsErbB ReceptorsFlagellinGene Expression RegulationHEK293 CellsHumansInterleukin-8LungLung DiseasesMiceMice, Inbred C57BLMitogen-Activated Protein KinasesMucin-1Myeloid Differentiation Factor 88ErbB ReceptorsFlagellinInterleukin-8Mitogen-Activated Protein KinasesMucin-1MYD88 protein, humanMyeloid Differentiation Factor 88NF-kappa BTLR5 protein, humanToll-Like Receptor 5Tumor Necrosis Factor-alpha

Identifiers

PMID22250084
PMCPMC3310431
OpenAlexW2113307778

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.